When One Antidepressant Is Not Enough: Aripiprazole, Quetiapine, Lithium, and Augmentation
Author: The Narcis editorial team · updated: August 2026
🩺 Medical review: awaiting confirmation by a medical reviewer · psychiatrist
Prepared by the Narcis editorial team. The author is a practising psychotherapist, not a physician. This is a review of official prescribing information and clinical guidelines, not a medical opinion: every source below is open and every claim can be checked.
This article explains how a medicine works and what research says about it. Dosing schedules are deliberately omitted. Only a doctor — a psychiatrist or GP — prescribes, changes or stops medication. Narcis is a psychotherapy platform and does not prescribe. Never start or stop a medicine based on an article: for some drugs, abrupt discontinuation is more dangerous than continuing. Approved indications for the same drug differ between countries.
Do not wait for the medicine to “kick in” if you notice:
a sharp worsening of your state · thoughts of self-harm · unusual agitation or signs of mania or hypomania · seizures · confusion · a severe allergic reaction. Seek medical help immediately. Where to turn →
“My doctor added an antipsychotic — does that mean they think I have psychosis?” The reaction is understandable. In fact, medications from other psychiatric classes are sometimes used to augment an antidepressant when the response is insufficient.
What is driving this
NICE recommends checking the less dramatic but crucial issues first: Is the diagnosis correct? Was the antidepressant taken regularly and for long enough? Is another condition maintaining the symptoms? Only then do clinicians discuss switching, adding psychotherapy, or pharmacological augmentation.
Aripiprazole has official evidence as adjunctive treatment for major depression after inadequate antidepressant response. In short-term trials, the additional benefit had a very concrete cost: pooled data showed akathisia in about 25% of patients taking aripiprazole versus 4% with placebo.
Quetiapine XR also has official US data as adjunctive treatment for MDD. In two six-week studies involving 936 patients, somnolence was common — about 37% and 43% with fixed doses of 150 and 300 mg respectively. Lithium is another important augmentation option, but it requires monitoring of blood levels, kidney function, thyroid function, and other parameters.
Why not add several drugs at once “just in case”? Because adverse effects, interactions, and diagnostic ambiguity increase. If the patient feels worse, it becomes harder to know which component is responsible. These strategies particularly benefit from shared decision-making and often specialist oversight.
One failed antidepressant does not make depression “treatment resistant.” The underlying issue may instead be bipolar-spectrum illness, substance use, a medical condition, inadequate treatment duration, or the wrong therapeutic target.
How this looks outside theory
After two unsuccessful medications, a patient may feel that augmentation means the doctor is “just adding more pills.” In reality, augmentation strategies have their own evidence and risks. What matters is not the number of medication names but the clinical rationale, prior response, monitoring, and regular reassessment.
What one fact does not prove
Benefit and discontinuation are separate questions. If this topic helped, that does not mean it can be stopped abruptly; symptoms after stopping do not automatically prove addiction in the same sense as addictive substances. Precise terminology and a clinician-guided plan matter.
What therapy works with here
If someone is frightened of medication, therapy can help distinguish reasonable concern from an anxiety-driven loop of endless checking. But a therapist should not pressure a client to take this topic against the prescriber’s or client’s decision. The role is to support informed choice and tolerance of uncertainty, not to become a second prescriber.
Four questions instead of a quick conclusion
For a prescriber conversation about “this topic,” bring your own data rather than an internet ranking: the target symptom, when it began, what has already been tried, other medicines and medical conditions, and which adverse effects would be especially difficult for you. After starting treatment, track changes in sleep, anxiety, mood, functioning, and side effects over time. Sudden deterioration, suicidal thoughts, marked agitation, signs of mania, an allergic reaction, or another acute symptom require prompt medical contact or emergency care. Do not change the dose or discontinue a prescription medicine on the basis of an article.
Medical note. Important: comparisons in this article are not individualized prescribing advice. Effectiveness and tolerability depend on diagnosis, comorbidities, other medicines, prior response, and individual risks.
Books and sources
• NICE NG222 — further-line and combination treatment
• DailyMed: Aripiprazole — adjunctive treatment of MDD
• DailyMed: Quetiapine XR — adjunctive MDD trials
If this topic resonated — you do not have to sit with it alone.
Therapy can be part of comprehensive care — find a specialist →Sources checked: August 2026. Guidelines and prescribing information change over time — if this article is old, check the original via the link.
This article is for information only and is not a substitute for an individual consultation with a specialist.